Literature DB >> 24467457

The first histopathological evidence of trimetazidine for the prevention of contrast-induced nephropathy.

Çağdaş Akgüllü1, Tevger Saruhan, Ufuk Eryilmaz, Murat Boyacıoğlu, Osman Alper Onbaşılı, Ibrahim Meteoğlu, Cavit Kum.   

Abstract

AIM: We aimed to investigate the prophylactic effects of trimetazidine (TMZ) against contrast-induced nephropathy (CIN) in rat kidneys. METHODS AND
RESULTS: 28 Wistar rats were divided into 4 groups of 7 rats each (control (C), contrast media (CM) TMZ, trimetazidin+contrast media groups (TMZ + CM). The administration of TMZ solution was done on d2, d3 and d4. Fifth day, contrast media was administered at a single dose. On d6 scarification was performed. The oxidant/antioxidant parameters were measured and histopathological scores were performed in kidney tissues. Most of the histopathological scores were significantly higher in the CM group as compared to other groups. Moreover, the scores of the TMZ + CM and C groups were not statistically different. CM group, had significantly higher levels of MDA compared to the C and CM + TMZ groups (562.82 ± 38.15 vs. 419.15 ± 49.01 and 507.34 ± 14.16 01 nmol/mg protein respectively) (p<0.001). CM group had significantly lower levels of SOD as compared to C, CM + TMZ and TMZ groups (p<0.05).
CONCLUSION: To the best of our knowledge, this study for the first time, histopathologically demonstrated the effectiveness of TMZ for the prevention of CIN.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24467457     DOI: 10.3109/0886022X.2014.880324

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  1 in total

1.  Efficacy of short-term cordyceps sinensis for prevention of contrast-induced nephropathy in patients with acute coronary syndrome undergoing elective percutaneous coronary intervention.

Authors:  Kai Zhao; Yu Lin; Yong-Jian Li; Sheng Gao
Journal:  Int J Clin Exp Med       Date:  2014-12-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.